Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Quoin Pharmaceuticals, Ltd. QNRX

Full chart Compare
Set alert

Price alert · QNRX

All alert types
4.02 USD +0.09 (+2.29%)

At closeNov 4, 2026, 4:00 PM EST

3.99 -0.03 -0.75%

After hours · Nov 4, 4:00 PM ET

3.88 Day range 4.03
3.25 52-week range 23.50
YTD
-72.14%
1 year
-59.23%

Financial health

Altman Z-Score

-13.64 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E -1.4×
FY 2016: -2.0×FY 2017: -2.9×FY 2018: -1.4×FY 2019: -2.9×FY 2020: -35.1×FY 2021: -3.8×FY 2022: -52.2×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -1.4×
FY 2016 5y median -1.4× FY 2025
P/S 0.0×
FY 2016: -29.0×FY 2017: 0.0×FY 2018: -27.6×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.6×
FY 2016: 1.1×FY 2017: 4.1×FY 2018: 2.1×FY 2019: 3.1×FY 2020: -11.2×FY 2021: 125×FY 2022: 66.3×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1.6×
FY 2016 5y median 1.6× FY 2025
P/FCF -1.6×
FY 2016: -2.0×FY 2017: -4.4×FY 2018: -1.1×FY 2019: -2.3×FY 2020: -50.6×FY 2021: -13.0×FY 2022: -56.3×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -1.6×
FY 2016 5y median -1.6× FY 2025
EV/EBITDA 242×
FY 2016: -1.7×FY 2017: -2.3×FY 2018: -0.5×FY 2019: -5.5×FY 2020: -47.9×FY 2021: -3.7×FY 2022: -57.0×FY 2023: 0.3×FY 2024: 0.4×FY 2025: 242×
FY 2016 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2016: -23.2×FY 2017: 0.0×FY 2018: -10.5×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -62.6%
FY 2016: -50.5%FY 2017: -22.9%FY 2018: -87.5%FY 2019: -42.6%FY 2020: -2.0%FY 2021: -7.7%FY 2022: -1.8%FY 2023: -6232.5%FY 2024: -9012.8%FY 2025: -62.6%
FY 2016 5y median -62.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 131.8%FY 2017: 0.0%FY 2018: 144.9%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -5470.4%FY 2017: 0.0%FY 2018: -5470.4%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -5470.4%FY 2017: 0.0%FY 2018: -5470.4%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -120.5%
FY 2016: 206.9%FY 2017: 187.3%FY 2018: 411.1%FY 2019: -36.3%FY 2020: 31.7%FY 2021: -3266.6%FY 2022: -126.7%FY 2023: -153.4%FY 2024: -97.4%FY 2025: -120.5%
FY 2016 5y median -126.7% FY 2025
ROIC -109.7%
FY 2016: 191.5%FY 2017: 134.4%FY 2018: 363.7%FY 2019: -29.8%FY 2020: 31.0%FY 2021: -126.8%FY 2022: -84.7%FY 2023: -109.2%FY 2024: -82.7%FY 2025: -109.7%
FY 2016 5y median -109.2% FY 2025
ROA -77.5%
FY 2016: 173.8%FY 2017: 116.3%FY 2018: 277.3%FY 2019: -25.3%FY 2020: -152.1%FY 2021: -229.4%FY 2022: -64.9%FY 2023: -71.4%FY 2024: -57.1%FY 2025: -77.5%
FY 2016 5y median -71.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 100.0%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -71.0%
FY 2016: 689.5%FY 2017: -33.6%FY 2018: 50.6%FY 2019: -110.2%FY 2020: -7.0%FY 2021: -263.0%FY 2022: -52.7%FY 2023: -1.3%FY 2024: -1.6%FY 2025: -71.0%
FY 2016 FY 2025
EPS (diluted) 99.5%
FY 2016: -13076891.9%FY 2017: -60.1%FY 2018: 38.3%FY 2019: 89.7%FY 2020: 92.1%FY 2021: -92.9%FY 2022: 99.5%FY 2023: -103061.1%FY 2024: 80.0%FY 2025: 99.5%
FY 2016 FY 2025
Free Cash Flow -72.3%
FY 2016: -98.0%FY 2017: -23.3%FY 2018: -33.7%FY 2019: 15.0%FY 2020: 74.5%FY 2021: -333.5%FY 2022: -37.6%FY 2023: 9.9%FY 2024: 0.1%FY 2025: -72.3%
FY 2016 FY 2025

Financial Health

Current Ratio 3.6×
FY 2016: 9.3×FY 2017: 7.0×FY 2018: 3.8×FY 2019: 5.1×FY 2020: 0.1×FY 2021: 1.8×FY 2022: 3.8×FY 2023: 3.2×FY 2024: 3.6×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
Quick Ratio 3.6×
FY 2016: 9.3×FY 2017: 7.0×FY 2018: 3.8×FY 2019: 5.1×FY 2020: 0.1×FY 2021: 1.8×FY 2022: 3.8×FY 2023: 3.2×FY 2024: 3.6×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: -0.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 243×
FY 2016: 0.4×FY 2017: 0.5×FY 2018: 0.9×FY 2019: 3.2×FY 2020: -0.6×FY 2021: 0.4×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.4×FY 2025: 243×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -3.8×FY 2020: -1.4×FY 2021: -5.6×FY 2022: -13.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 13.3%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -695.7%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31